JPMorgan Upgrades United Therapeutics Corp. (UTHR) to Neutral
Tweet Send to a Friend
JPMorgan upgraded United Therapeutics Corp. (NASDAQ: UTHR) from Underweight to Neutral.
This article: 56 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This article: 56 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
